The study showed that some COVID-19 patients may be associated with different degrees of liver biochemistry abnormalities, and ALT and AST higher than the upper limit of normal reference value were found in 16 cases (27.6%) and 12 cases (20.7%,), respectively, with the median slightly higher in the severe group than that in the mild group. The gene discussed is GPT; the disease is COVID-19.